It was confirmed that this was an AFAR, and then 9 pyrarentypic studies were conducted SIzins identification and resistance (GenoZA type MTBDR plus, Hain Livescience GmbH, NehECpeak, Germany) and rifampicin susceptibility to isoniazid (REambucomycin).